President Donald Trump speaks speaks on the latest developments of the coronavirus outbreak, while flanked by White House coronavirus response coordinator Debbie Birx (L), and U.S. Surgeon General Jerome Adams (R), in the James Brady Press Briefing Room at the White House March 19, 2020. (Photo by Chip Somodevilla/Getty Images)
President Donald Trump in a press conference on Thursday said the Food and Drug Administration is fast-tracking efforts to approve an antiviral therapy, best known for treating malaria, for use in coronavirus cases.
The drug, hydroxychloroquine, was developed more than a half-century ago and is approved for treating malaria, arthritis, and other ailments. Reports out of China and Italy suggest the drug may help, but there is no hard data yet.
"We're going to be able to make that drug available almost immediately," Trump said.
The FDA is working to conduct a "large, pragmatic clinical trial" quickly to confirm the drug's benefit to coronavirus patients, said Commissioner Dr. Stephen Hahn.
He also tempered the president's optimism about the still-untested solution.
"What's also important is not to provide false hope," he said. "We may have the right drug, but it might not be in the appropriate dosage form right now, and it might do more harm than good."
New antiviral therapies face a shorter and less arduous approval process than vaccines, several of which are under development with 12 to 18-month timelines.
"The therapies are something we could move on much faster potentially," Trump said.
He claimed the administration "slashed red tape" to develop new vaccines and therapies.
The president also held out on confirming whether he would invoke the Defense Production Act, which he signed on Wednesday, to mandate the production of needed medical supplies such as N95 respirators and surgical masks.
"If we find that we need something, then we will do that," he said.
Trump repeated that he was open to the federal government buying equity stakes in the airline, cruise, hospitality, and other industries hurt by the outbreak.
The press conference opened with more controversial language placing the blame squarely on China for the outbreak, despite concerns voiced about potentially exacerbating a backlash against Asian Americans.
"We continue our relentless effort to defeat the Chinese virus," Trump said.
A new report by the Foreign Correspondents Club of China warns that press freedom in the most populous country in the world is declining at an alarming speed. Cheddar News speaks with Steven Butler, Asia Program Coordinator at the Committee to Protect Journalists, about the hardships journalists face in China.
Rep. Nancy Mace (R-S.C. 1st District) joined Cheddar to discuss her cannabis legalization bill, the States Reform Act, and the prospects for gaining bipartisan support for a bill that has garnered the endorsement of e-commerce giant Amazon. This legislation is supported by businesses large and small, Amazon obviously being the most recent and largest business to support it," Mace said. "They don't want to sell pot. But what it does do is it affects their working employment pool." She stated that 10 percent of eligible new hires for Amazon are affected by restrictive marijuana laws. The representative also explained that the bill leaves equity provisions up to the states rather than mandating them on a federal level.
After a number of tragic subway incidents, the MTA is facing increased pressure to install subway platform screens to help prevent injury or death. However, according to an earlier report from the MTA, installing these prevented measures isn't feasible. New York City Council Member Keith Powers, joined Cheddar to discuss more.
Across the country, states are working to redraw their congressional lines in what is often known as gerrymandering. These news lines are expected to determine the balance of power between Democrats and Republicans within the next decade. Senior Counsel for the Brennan Center's Democracy Program, Michael Li, joined Cheddar to discuss more.
The state of California is officially planning to close its death row in the next two years. That state's governor Democrat Gavin Newsom says the plan is now to move all condemned inmates to other prisons and turn it into, as he calls it, a positive healing environment. Former U. S. Assistant Attorney and Legal Analyst, David Katz, joined Cheddar to discuss more.
Anthony Saccaro, Founder and President of Providence Financial, joins Cheddar News' Closing Bell, where he elaborates on why he is excited that the market is beginning to rebound and believes February has the potential to be a good month after a turbulent January.
Cryptocurrency is expected to become a part of our daily lives — but what sort of environmental impact does it have? As the U.S. becomes the crypto mining capital of the world, climate advocates are worried about mining companies reopening old coal plants, using massive amounts of energy, wasteful hardware, and more. Congressional Democrats led by Senator Elizabeth Warren are demanding answers from mining firms about their electricity use and waste levels. John Belizaire, CEO of Soluna Computing, joins Cheddar Climate to discuss the congressional letters, how crypto mining can become a green industry, and more.
The Supreme Court will reconsider race-based affirmative action in college admissions. The court will examine admissions policies at Harvard University and The University of North Carolina Chapel Hill, which count the race of applicants as a factor in admissions. The court has upheld affirmative action policies in the past, saying it helps to create more diverse student bodies. However, the conservative Supreme Court could be skeptical and even possibly hostile to such policies. Nick Anderson, Higher Education Writer, Washington Post joined Cheddar's Opening Bell to discuss.
